Related references
Note: Only part of the references are listed.Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation
Hakon Reikvam et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Roles of PKC isoforms in the induction of apoptosis elicited by aberrant Ras
T. Zhu et al.
ONCOGENE (2010)
PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: Results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study
Greg Siller et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2009)
The protein kinase C agonist PEP005 increases NF-κB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells
Astrid Marta Olsnes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Epithelial-to-Mesenchymal Transition and Resistance to Ingenol 3-Angelate, a Novel Protein Kinase C Modulator, in Colon Cancer Cells
Aida Ghoul et al.
CANCER RESEARCH (2009)
Heat Shock Protein 90-a Potential Target in the Treatment of Human Acute Myelogenous Leukemia
H. Reikvam et al.
CURRENT CANCER DRUG TARGETS (2009)
Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis
Lawrence Anderson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies
Thuy T. T. Le et al.
VACCINE (2009)
Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells
K. A. Benhadji et al.
BRITISH JOURNAL OF CANCER (2008)
The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-δ dependent manner
Peter Hampson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Antibody-drug conjugates for cancer therapy
Paul J. Carter et al.
CANCER JOURNAL (2008)
Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412
C. M. Dayan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Gemtuzumab ozogamicin: an anti-CD33 immunoconjugate for the treatment of acute myeloid leukaemia
Roberto Stasi
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
The PKCδ-Abl complex communicates ER stress to the mitochondria -: an essential step in subsequent apoptosis
Xin Qi et al.
JOURNAL OF CELL SCIENCE (2008)
Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells
Maria Serova et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Protein kinase C signalling in leukemia
Amanda J. Redig et al.
LEUKEMIA & LYMPHOMA (2008)
Protein kinase Cδ and apoptosis
M. E. Reyland
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Protein kinase C δ activates IκB-kinase α to induce the p53 tumor suppressor in response to oxidative stress
Tomoko Yamaguchi et al.
CELLULAR SIGNALLING (2007)
T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-γ that can be further increased by a novel protein kinase C agonist PEP005
Elisabeth Ersvær et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
The role of PKC and PDK1 in monocyte lineage specification by Ras
Lorna Pearn et al.
BLOOD (2007)
Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells
Oystein Bruserud et al.
HAEMATOLOGICA (2007)
Photochemical internalization:: A new tool for drug delivery
Kristian Berg et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2007)
Ultrasound-directed drug delivery
Michiel Postema et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2007)
Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complex
Elisabeth Ersvaer et al.
HEMATOLOGY (2007)
Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate
Jodie M. Challacombe et al.
JOURNAL OF IMMUNOLOGY (2006)
Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway
Sarah-Jane Cozzi et al.
CANCER RESEARCH (2006)
Protein kinase C (PKC) family in cancer progression
J Koivunen et al.
CANCER LETTERS (2006)
Suppression of apoptosis in the protein kinase Cδ null mouse in vivo
MJ Humphries et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils
R Selvatici et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
The proapoptotic tumor suppressor protein kinase C-delta is lost in human squamous cell carcinomas
AM D'Costa et al.
ONCOGENE (2006)
Systemic targeted radionuclide therapy: Potential new areas
Jeffrey Y. C. Wong
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Subversion of protein kinase C alpha signaling in hematopoietic progenitor cells results in the generation of a B-cell chronic lymphocytic leukemia-like population in vivo
R Nakagawa et al.
CANCER RESEARCH (2006)
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma
CP Hans et al.
MODERN PATHOLOGY (2005)
Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy
Q Pan et al.
CANCER RESEARCH (2005)
PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC
P Hampson et al.
BLOOD (2005)
Role of protein kinase C-δ (PKC-δ) in the generation of the effects of IFN-α in chronic myelogenous leukemia cells
S Kaur et al.
EXPERIMENTAL HEMATOLOGY (2005)
Characterization of the interaction of ingenol 3-angelate with protein kinase C
N Kedei et al.
CANCER RESEARCH (2004)
Antitumor activity of 3-ingenyl angelate: Plasma membrane and mitochondrial disruption and necrotic cell death
SM Ogbourne et al.
CANCER RESEARCH (2004)
The enigmatic protein kinase Cδ:: complex roles in cell proliferatin and survival
DN Jackson et al.
FASEB JOURNAL (2004)
Inhibition of human p53 basal transcription by down-regulation of protein kinase Cδ
T Abbas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase Cα
C Kerfoot et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma
PD Ainsworth et al.
EUROPEAN JOURNAL OF CANCER (2004)
Distinctive activation mechanisms and functions for protein kinase Cδ
SF Steinberg
BIOCHEMICAL JOURNAL (2004)
Transcriptional and post-transcriptional regulation of the PKCδ gene by etoposide in L1210 murine leukemia cells:: Implication of PKCδ autoregulation
SY Shin et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Protein kinase C θ is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias
P Blay et al.
CLINICAL CANCER RESEARCH (2004)
Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas
A Varga et al.
EUROPEAN UROLOGY (2004)
Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm
AC Newton
BIOCHEMICAL JOURNAL (2003)
Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers
ER Zabarovsky et al.
ONCOGENE (2002)
Protein kinase Cδ controls self-antigen-induced B-cell tolerance
I Mecklenbräuker et al.
NATURE (2002)
Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ
A Miyamoto et al.
NATURE (2002)
Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder
L Langzam et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2001)
Loss of expression of protein kinase C β is a common phenomenon in human malignant melanoma:: a result of transformation or differentiation?
EM Gilhooly et al.
MELANOMA RESEARCH (2001)
Altered expression and localization of PKC eta in human breast tumors
PA Masso-Welch et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Protein kinase C (PKC) isoenzymes immunohistochemistry in lymph node revealing solution-fixed, paraffin-embedded bladder tumors
R Koren et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2000)
Share Paper
